Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2018 07:30 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics to Host First Quarter 2018 Financial Results Conference Call on May 9, 2018

DALLAS and FORT WORTH, Texas, May 02, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
March 15, 2018 07:00 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results

DALLAS and FORT WORTH, Texas, March 15, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
March 08, 2018 07:30 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics to Host Fourth Quarter and Year-End 2017 Financial Results Conference Call on March 15, 2017

DALLAS and FORT WORTH, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
March 05, 2018 08:00 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics to Present at the Cowen & Co. Annual Health Care Conference

DALLAS and FORT WORTH, Texas, March 05, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
February 26, 2018 08:00 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics Launches Adzenys ER™ (amphetamine) Extended-Release Oral Suspension in U.S. for the Treatment of ADHD in Patients 6 Years and Older

DALLAS and FORT WORTH, Texas, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing...
January 10, 2018 08:00 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics to Present Three Posters at the Upcoming American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting

DALLAS and FORT WORTH, Texas, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
November 28, 2017 08:00 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics to Participate in Two December Conferences

DALLAS and FORT WORTH, Texas, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
November 08, 2017 07:00 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics Reports Third Quarter 2017 Financial Results

DALLAS and FORT WORTH, Texas, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
November 07, 2017 08:00 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics to Present at the Stifel 2017 Healthcare Conference

DALLAS/FORT WORTH, Texas, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
November 02, 2017 08:00 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics to Host Third Quarter 2017 Financial Results Conference Call on November 8, 2017

DALLAS/FORT WORTH, Texas, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right